Korean J Urol.  1982 Aug;23(5):610-616.

Clinical Study on Renal Cell Carcinoma

Affiliations
  • 1Department of Urology, College of Medicine, Busan National University, Busan, Korea.

Abstract

The clinical observation was made on 28 patients with renal cell carcinoma who admitted to the Dept. of Urology, Busan National University Hospital, during the period from January, 1971 to December, 1980. The following results were obtained: 1. Renal Cell carcinoma was more common in male than female and the left kidney than the right, and was most common in the sixth decade. Hematuria was the most common initial symptom and was followed by flank pain and palpable mass. The classic symptom triad of renal cell carcinoma was found in about one fifth of the cases. 2. The abnormal laboratory findings were anemia (50.0%), positive CRP (53.3%), raised a-globulin {46.7%) and raised ESR (35.7%). Metastasis at admission was seen in one fourth of the cases, and the most common site of distant metastasis was the lung. 3. Of 28 cases of renal cell carcinomas, simple nephrectomy was performed on 19, radical nephrectomy on 6, and explorative laparotomy on 3. Of 19 cases of simple nephrectomies, the adjuvant therapy was done on 7.Of 6 cases of radical nephrectomies, the adjuvant therapy was done on 3. 4. Poor prognosis was correlated with palpable mass, raised ESR, and positive CRP. The radical nephrectomy with or without adjuvant therapy was better than simple nephrectomy. 5. The relative survival rate of the patients with the tumors of low stage and low grade was better than that of high stage and high grade. The weight of the tumor was related with prognosis, but the cell type was not.

Keyword

renal cell carcinoma

MeSH Terms

Anemia
Busan
Carcinoma, Renal Cell*
Female
Flank Pain
Hematuria
Humans
Kidney
Laparotomy
Lung
Male
Neoplasm Metastasis
Nephrectomy
Prognosis
Survival Rate
Urology
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr